TYPE 2 DIABETES AND CARDIOVASCULAR COMPLICATIONS: IS IT POSSIBLE TO IMPROVE PROGNOSIS BY GLUCOSE LOWERING THERAPY?

Regardless the fact that type 2 diabetes (DM2) is related to higher risk of cardiovascular diseases (CVD) development and complications, incl. heart failure (HF), usage of the most of glucose lowering drugs (GLD) does not only improve life prognosis, but might increase the risk of HF. Inhibitors of...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Zh. D. Kobalava, G. К. Kiyakbaev
Format: Artigo
Sprog:Russo
Udgivet: «FIRMA «SILICEA» LLC 2018-09-01
Serier:Российский кардиологический журнал
Fag:
diabetes type 2
cardiovascular complications
heart failure
glucose lowering therapy
sglt2 inhibitor (gliflozin)
Online adgang:https://russjcardiol.elpub.ru/jour/article/view/2918
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker